IBDEI0OR ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12133,1,2,0)
 ;;=2^V58.64
 ;;^UTILITY(U,$J,358.3,12133,1,5,0)
 ;;=5^L/T (Current) NSAIDS Use
 ;;^UTILITY(U,$J,358.3,12133,2)
 ;;=^329979
 ;;^UTILITY(U,$J,358.3,12134,0)
 ;;=V58.65^^66^729^30
 ;;^UTILITY(U,$J,358.3,12134,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12134,1,2,0)
 ;;=2^V58.65
 ;;^UTILITY(U,$J,358.3,12134,1,5,0)
 ;;=5^L/T (Current) Steroids Use
 ;;^UTILITY(U,$J,358.3,12134,2)
 ;;=^329980
 ;;^UTILITY(U,$J,358.3,12135,0)
 ;;=V58.66^^66^729^25
 ;;^UTILITY(U,$J,358.3,12135,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12135,1,2,0)
 ;;=2^V58.66
 ;;^UTILITY(U,$J,358.3,12135,1,5,0)
 ;;=5^L/T (Current) Aspirin Use
 ;;^UTILITY(U,$J,358.3,12135,2)
 ;;=^331584
 ;;^UTILITY(U,$J,358.3,12136,0)
 ;;=V58.67^^66^729^27
 ;;^UTILITY(U,$J,358.3,12136,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12136,1,2,0)
 ;;=2^V58.67
 ;;^UTILITY(U,$J,358.3,12136,1,5,0)
 ;;=5^L/T (Current) Insulin Use
 ;;^UTILITY(U,$J,358.3,12136,2)
 ;;=^331585
 ;;^UTILITY(U,$J,358.3,12137,0)
 ;;=V58.68^^66^729^26
 ;;^UTILITY(U,$J,358.3,12137,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12137,1,2,0)
 ;;=2^V58.68
 ;;^UTILITY(U,$J,358.3,12137,1,5,0)
 ;;=5^L/T (Current) Bisphos Use
 ;;^UTILITY(U,$J,358.3,12137,2)
 ;;=^340624
 ;;^UTILITY(U,$J,358.3,12138,0)
 ;;=V58.69^^66^729^29
 ;;^UTILITY(U,$J,358.3,12138,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12138,1,2,0)
 ;;=2^V58.69
 ;;^UTILITY(U,$J,358.3,12138,1,5,0)
 ;;=5^L/T (Current) Other Meds Use
 ;;^UTILITY(U,$J,358.3,12138,2)
 ;;=^303460
 ;;^UTILITY(U,$J,358.3,12139,0)
 ;;=V58.83^^66^729^50
 ;;^UTILITY(U,$J,358.3,12139,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12139,1,2,0)
 ;;=2^V58.83
 ;;^UTILITY(U,$J,358.3,12139,1,5,0)
 ;;=5^Therapeutic Drug Monitoring
 ;;^UTILITY(U,$J,358.3,12139,2)
 ;;=^322076
 ;;^UTILITY(U,$J,358.3,12140,0)
 ;;=V62.5^^66^729^32
 ;;^UTILITY(U,$J,358.3,12140,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12140,1,2,0)
 ;;=2^V62.5
 ;;^UTILITY(U,$J,358.3,12140,1,5,0)
 ;;=5^Legal Circumstances
 ;;^UTILITY(U,$J,358.3,12140,2)
 ;;=^175799
 ;;^UTILITY(U,$J,358.3,12141,0)
 ;;=V79.1^^66^730^1
 ;;^UTILITY(U,$J,358.3,12141,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12141,1,2,0)
 ;;=2^V79.1
 ;;^UTILITY(U,$J,358.3,12141,1,5,0)
 ;;=5^Alcohol Screen
 ;;^UTILITY(U,$J,358.3,12141,2)
 ;;=^295678
 ;;^UTILITY(U,$J,358.3,12142,0)
 ;;=V61.21^^66^730^8
 ;;^UTILITY(U,$J,358.3,12142,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12142,1,2,0)
 ;;=2^V61.21
 ;;^UTILITY(U,$J,358.3,12142,1,5,0)
 ;;=5^Victim Child Abuse Counseling
 ;;^UTILITY(U,$J,358.3,12142,2)
 ;;=^304301
 ;;^UTILITY(U,$J,358.3,12143,0)
 ;;=V65.40^^66^730^2
 ;;^UTILITY(U,$J,358.3,12143,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12143,1,2,0)
 ;;=2^V65.40
 ;;^UTILITY(U,$J,358.3,12143,1,5,0)
 ;;=5^Counseling NOS
 ;;^UTILITY(U,$J,358.3,12143,2)
 ;;=^87449
 ;;^UTILITY(U,$J,358.3,12144,0)
 ;;=V65.42^^66^730^7
 ;;^UTILITY(U,$J,358.3,12144,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12144,1,2,0)
 ;;=2^V65.42
 ;;^UTILITY(U,$J,358.3,12144,1,5,0)
 ;;=5^Substance Use/Abuse Counseling
 ;;^UTILITY(U,$J,358.3,12144,2)
 ;;=^303467
 ;;^UTILITY(U,$J,358.3,12145,0)
 ;;=V65.44^^66^730^3
 ;;^UTILITY(U,$J,358.3,12145,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12145,1,2,0)
 ;;=2^V65.44
 ;;^UTILITY(U,$J,358.3,12145,1,5,0)
 ;;=5^HIV Counseling
 ;;^UTILITY(U,$J,358.3,12145,2)
 ;;=^303469
 ;;^UTILITY(U,$J,358.3,12146,0)
 ;;=V65.49^^66^730^5
 ;;^UTILITY(U,$J,358.3,12146,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12146,1,2,0)
 ;;=2^V65.49
 ;;^UTILITY(U,$J,358.3,12146,1,5,0)
 ;;=5^Oth Specified Counseling
 ;;^UTILITY(U,$J,358.3,12146,2)
 ;;=^303471
